Washington, DC 20006-5349
HELPLINE
It was recently reported that a clinical trial that randomized patients to receive hypnosis and cognitive therapy had a statistically significant reduction in their fatigue…
The Mesothelioma Applied Research Foundation announced today that the 2014 recipient of its Pioneer Award is Michele Carbone, MD, PhD, for his remarkable achievements in…
On October 27 – 30, Mary Hesdorffer, the executive director of the Mesothelioma Applied Research Foundation (Meso Foundation), and Melinda Kotzian, the chief executive officer…
Today, the Science Translational Medicine journal published the article “Major Cancer Regressions in Mesothelioma After Treatment with an Anti-Mesothelin Immunotoxin and Immune Suppression” by Dr.…
Cancer therapies often result in xerostomia (dry mouth), a condition that can lead to increased risk of infection and cavities. Bacteria in the mouth are…
Patients with peritoneal mesothelioma appear to be at an increased risk of bowel obstructions either due to disease or perhaps as a consequence of their…
When patients and their families need help following a diagnosis or throughout treatment, the Meso Foundation is there for them – day or night. But…
Last week, the Journal of Thoracic Oncology published the results of a study looking into the overexpression of the ephrin B2 receptor (EPHB2) in patients…
Personalized medicine is the ability to select a biologic target and direct therapy against this target. It is associated with improved outcomes in a number…
By Lee Krug, MD, Memorial Sloan-Kettering Cancer Center The American Society of Clinical Oncology meeting was held from June 1-4 in Chicago. This is the…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
